Skip to main content
. 2021 Mar 18;2021(3):CD013881. doi: 10.1002/14651858.CD013881
Outcome No. of studies No. of participants Statistical method Effect size
Time to clinical improvement 6 2118 Hazard Ratio (95% CI) 1.23 (1.08 to 1.39)
Time to WHO progression score (level 7 and above) 3 762 Hazard Ratio (95% CI) 0.62 (0.42 to 0.91)
Time to death 3 1152 Hazard Ratio (95% CI) 0.65 (0.51 to 0.83)